Analysis of serum and urinal copper and zinc in chinese northeast population with the prediabetes or diabetes with and without complications

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Xu, Jiancheng ^a   Zhou, Qi ^b   Liu, Gilbert ^c   Tan, Yi ^c   Cai, Lu ^c  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMPAIRED GLUCOSE TOLERANCES; MATCHED CONTROLS; METABOLIC SYNDROMES; NORTHEAST CHINA; PERIPHERAL NEUROPATHY; POTENTIAL IMPACTS; SIMVASTATIN TREATMENT; TYPE 1 DIABETES;

COPPER; PATIENT TREATMENT; ZINC;

BODY FLUIDS;

COPPER; GLUCOSE; SIMVASTATIN; ZINC; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CHINA; CHINESE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PREDICTIVE VALUE; SERUM; SEX DIFFERENCE; URINALYSIS; ZINC BLOOD LEVEL; ZINC URINE LEVEL; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHILD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED; URINE; YOUNG ADULT; ASIAN;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHINA; COPPER; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; SIMVASTATIN; YOUNG ADULT; ZINC;

EID: 84885624282     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/635214     Document Type: Article

References (45)

1. Hu F. B., Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011 34 6 1249 1257 2-s2.0-80051986265 10.2337/dc11-0442
2. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., Shan Z., Liu J., Tian H., Ji Q., Zhu D., Ge J., Lin L., Chen L., Guo X., Zhao Z., Li Q., Zhou Z., Shan G., He J., Prevalence of diabetes among men and women in China. The New England Journal of Medicine 2010 362 12 1090 1101 2-s2.0-77950263954 10.1056/NEJMoa0908292
3. Hu F. B., Manson J. E., Stampfer M. J., Colditz G., Liu S., Solomon C. G., Willett W. C., Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. The New England Journal of Medicine 2001 345 11 790 797 2-s2.0-0035856017 10.1056/NEJMoa010492
4. Friederich M., Hansell P., Palm F., Diabetes, oxidative stress, nitric oxide and mitochondria function. Current Diabetes Reviews 2009 5 2 120 144 2-s2.0-68349119363 10.2174/157339909788166800
5. Cheng Z., Tseng Y., White M. F., Insulin signaling meets mitochondria in metabolism. Trends in Endocrinology and Metabolism 2010 21 10 589 598 2-s2.0-77957229010 10.1016/j.tem.2010.06.005
6. Viktorínová A., Tošerová E., Križko M., Ďuračková Z., Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009 58 10 1477 1482 2-s2.0-70149085206 10.1016/j.metabol.2009.04.035
7. Li B., Tan Y., Sun W., Fu Y., Miao L., Cai L., The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. Toxicol Mech Methods 2013 23 1 27 33
8. Li B., Liu S., Miao L., Cai L., Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Experimental Diabetes Research 2012 2012 7 216512 10.1155/2012/216512
9. Liu Q., Sun L., Tan Y., Wang G., Lin X., Cai L., Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Current Medicinal Chemistry 2009 16 1 113 129 2-s2.0-61949188604 10.2174/ 092986709787002862
10. Sun L., Franco O. H., Hu F. B., Cai L., Yu Z., Li H., Ye X., Qi Q., Wang J., Pan A., Liu Y., Lin X., Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. Journal of Clinical Endocrinology and Metabolism 2008 93 12 4690 4696 2-s2.0-57349181284 10.1210/jc.2008-1159
11. Sun L., Yu Y., Huang T., An P., Yu D., Yu Z., Li H., Sheng H., Cai L., Xue J., Jing M., Li Y., Lin X., Wang F., Associations between ionomic profile and metabolic abnormalities in human population. PLoS ONE 2012 7 6 e38845 10.1371/journal.pone.0038845
12. Zheng Y., Li X.-K., Wang Y., Cai L., The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 2008 32 1-2 135 145 2-s2.0-39349103963 10.1080/03630260701727077 (Pubitemid 351264519)
13. DiSilvestro R. A., Zinc in relation to diabetes and oxidative disease. Journal of Nutrition 2000 130 supplement 5 109S 1511S 2-s2.0-0034016157
14. Forbes J. M., Coughlan M. T., Cooper M. E., Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008 57 6 1446 1454 2-s2.0-48249085391 10.2337/db08-0057
15. Walter R. M. Jr., Uriu-Hare J. Y., Olin K. L., Oster M. H., Anawalt B. D., Critchfield J. W., Keen C. L., Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991 14 11 1050 1056 2-s2.0-0025936532
16. Galhardi C. M., Diniz Y. S., Faine L. A., Rodrigues H. G., Burneiko R. C. M., Ribas B. O., Novelli E. L. B., Toxicity of copper intake: Lipid profile, oxidative stress and susceptibility to renal dysfunction. Food and Chemical Toxicology 2004 42 12 2053 2060 2-s2.0-7044269391 10.1016/j.fct.2004.07.020 (Pubitemid 39421507)
17. Xu J., Xu W., Yao H., Sun W., Zhou Q., Cai L., Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population. PLoS ONE 2013 8 2 e56750 10.1371/journal.pone. 0056750
18. Leibowitz D., Jacobs J. M., Stessman-Lande I., Cohen A., Gilon D., Ein-Mor E., Stessman J., Cardiac structure and function and dependency in the oldest old. Journal of the American Geriatrics Society 2011 59 8 1429 1434 2-s2.0-80051782745 10.1111/j.1532-5415.2011.03534.x
19. Faber S., Zinn G. M., Kern J. C. II, Skip Kingston H. M., The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009 14 3 171 180 2-s2.0-66149089999 10.1080/ 13547500902783747
20. George J., Bhatia V. N., Balakrishnan S., Ramu G., Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states. International Journal of Leprosy 1991 59 1 20 24 2-s2.0-0025754798
21. Naka T., Kaneto H., Katakami N., Matsuoka T. A., Harada A., Yamasaki Y., Matsuhisa M., Shimomura I., Association of serum copper levels and glycemic control in patients with type 2 diabetes. Endocrine Journal 2013 60 3 393 396
22. Zargar A. H., Shah N. A., Masoodi S. R., Laway B. A., Dar F. A., Khan A. R., Sofi F. A., Wani A. I., Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgraduate Medical Journal 1998 74 877 665 668 2-s2.0-0031794777 (Pubitemid 28508483)
23. Mateo M. C. M., Bustamante J. B., Cantalapiedra M. A. G., Serum zinc copper and insulin in diabetes mellitus. Biomedicine Express 1978 29 2 56 58 2-s2.0-0017880428
24. Basaki M., Saeb M., Nazifi S., Shamsaei H. A., Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biological Trace Element Research 2012 148 161 164 2-s2.0-84857001703 10.1007/s12011-012-9360-6
25. Ferdousi S., Mia A. R., Serum levels of copper and zinc in newly diagnosed type-2 diabetic subjects. Mymensingh Medical Journal 2012 21 3 475 478
26. Isbir T., Tamer L., Taylor A., Isbir M., Zinc, copper and magnesium status in insulin-dependent diabetes. Diabetes Research 1994 26 1 41 45 2-s2.0-0028700552
27. Estakhri M., Djazayery A., Eshraghian M. R., Majdzadeh R., Jalali M., Karamizadeh Z., Chamari M., Peyrovi Milani M., Serum zinc levels in children and adolescents with type-1 diabetes mellitus. Iranian Journal of Public Health 2011 40 4 83 88 2-s2.0-84255205278
28. Bideci A., Çamurdan M. O., Cinaz P., Dursun H., Demirel F., Serum zinc, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 2005 18 10 1007 1011 2-s2.0-28644437051 (Pubitemid 41749107)
29. Terres-Martos C., Navarro-Alarcon M., Martin-Lagos F., Serum zinc and copper concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes. Journal of Trace Elements in Medicine and Biology 1998 12 1 44 49 10.1016/S0946-672X(98)80020-5 (Pubitemid 28241847)
30. Tuvemo T., Gebre-Medhin M., The role of trace elements in juvenile diabetes mellitus. Pediatrician 1983 12 4 213 219 2-s2.0-0020862598
31. Talaei A., Jabari S., Bigdeli M. H., Farahani H., Siavash M., Correlation between microalbuminuria and urinary copper in type two diabetic patients. Indian Journal of Endocrinology and Metabolism 2011 15 4 316 319
32. Flores C. R., Puga M. P., Wrobel K., Garay Sevilla M. E., Wrobel K., Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications. Diabetes Research and Clinical Practice 2011 91 3 333 341 2-s2.0-79952363498 10.1016/j.diabres.2010.12.014
33. Caner Karahan S., Deer O., Örem A., Uçar F., Erem C., Alver A., Onder E., The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine 2001 39 2 109 115 2-s2.0-0035049119 10.1515/CCLM.2001.019 (Pubitemid 32318473)
34. Car N., Car A., Granic M., Skrabalo Z., Momcilovic B., Zinc and copper in the serum of diabetic patients. Biological Trace Element Research 1992 32 325 329 2-s2.0-0026554646
35. Cai L., Li X.-K., Song Y., Cherian M. G., Essentiality, toxicology and chelation therapy of zinc and copper. Current Medicinal Chemistry 2005 12 23 2753 2763 2-s2.0-27744491186 10.2174/092986705774462950 (Pubitemid 41601572)
36. Cooper G. J., Selective divalent copper chelation for the treatment of diabetes mellitus. Current Medicinal Chemistry 2012 19 17 2828 2860 10.2174/092986712800609715
37. Cooper G. J. S., Chan Y.-K., Dissanayake A. M., Leahy F. E., Keogh G. F., Frampton C. M., Gamble G. D., Brunton D. H., Baker J. B., Poppitt S. D., Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes 2005 54 5 1468 1476 2-s2.0-20944436062 10.2337/diabetes.54.5.1468 (Pubitemid 40586679)
38. Lu J., Gong D., Choong S. Y., Xu H., Chan Y.-K., Chen X., Fitzpatrick S., Glyn-Jones S., Zhang S., Nakamura T., Ruggiero K., Obolonkin V., Poppitt S. D., Phillips A. R. J., Cooper G. J. S., Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments. Diabetologia 2010 53 6 1217 1226 2-s2.0-77952096923 10.1007/s00125-010-1698-8
39. Bakker S. J. L., Navis G., Gans R. O. B., Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes. Diabetologia 2009 52 10 2244 2-s2.0-69949177089 10.1007/s00125-009-1495-4
40. Cooper G. J. S., Phillips A. R. J., Choong S. Y., Leonard B. L., Crossman D. J., Brunton D. H., Saafi E. L., Dissanayake A. M., Cowan B. R., Young A. A., Occleshaw C. J., Chan Y.-K., Leahy F. E., Keogh G. F., Gamble G. D., Allen G. R., Pope A. J., Boyd P. D. W., Poppitt S. D., Borg T. K., Doughty R. N., Baker J. R., Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004 53 9 2501 2508 2-s2.0-4344702433 10.2337/diabetes.53.9.2501 (Pubitemid 39145611)
41. Skyler J. S., Diabetic complications: the importance of glucose control. Endocrinology and Metabolism Clinics of North America 1996 25 2 243 254 2-s2.0-0029948733 10.1016/S0889-8529(05)70323-6 (Pubitemid 26195620)
42. O'Sullivan E. P., Dinneen S. F., Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years. Evidence-Based Medicine 2009 14 1 9 10 2-s2.0-61749093958 10.1136/ebm.14.1.9
43. Mattila T. K., De Boer A., Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus. Drugs 2010 70 17 2229 2245 2-s2.0-78449281681 10.2165/11585220-000000000-00000
44. Zhu C. H., Zhang S. S., Kong Y., Bi Y. F., Wang L., Zhang Q., Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type II diabetes mellitus. International Ophthalmology 2013 6 2 141 145
45. Ghayour-Mobarhan M., Lamb D. J., Taylor A., Vaidya N., Livingstone C., Wang T., Ferns G. A. A., Effect of statin therapy on serum trace element status in dyslipidaemic subjects. Journal of Trace Elements in Medicine and Biology 2005 19 1 61 67 2-s2.0-24344482867 10.1016/j.jtemb.2005.06.003 (Pubitemid 41253919)